Stocks to watch: DS Smith, Novacyt, Morrisons, Avacta Group and Capita PLC

The following FTSE listed stocks Novacyt (LON: NCYT) DS Smith (LON: SMDS), Morrisons (LON: MRW), Avacta Group (LON: AVCT), Capita PLC (LON: CPI), are set to make headlines today.

  1. Smith (DS) PLC (LON: SMDS)

UK-based packaging company DS Smith announced its full year results for the period ending 30 April 2021, today. The company reported a 1 per cent decline in revenue, however, corrugated box volume growth increased by 3.5 per cent.

SMDS had previously said it saw its momentum to keep going in H2 2021 due to a rise in sales, is US business segment reporting a better than forecasted performance, among other factors.

SMDS’ shares closed at GBX 432.40, up by 2.61 per cent on 21 June.

  1. Novacyt S.A. (LON: NCYT)

FTSE AIM 100 index constituent, Novacyt, a British-French biotechnology company focused on clinical diagnostics, announced its FY 2020 results today.

NCYT’s Group consolidated revenue surged over 20 times to £277.2 million as compared to £11.5 million in 2019. The company’s results are on expected lines as it had announced guidance of its FY 2020 revenue to increase to about £277 million in an update in January. Group margins increased to 76.3 per cent in 2020 from 64.0 per cent in 2019.

NCYT’s shares had closed at GBX 357.50, down by 8.52 per cent on 21 June.

  1. MORRISON (WM) SUPERMARKETS PLC (LON: MRW)

FTSE 250 listed supermarket company Morrisons is one of the largest supermarket chains in the UK. MRW’s shares soared to over 34 per cent on Monday after it rejected a takeover offer from US-based private equity firm Clayton Dubilier & Rice.

MRW was offered a £5.5 billion in bid offer, at a proposed 230 pence per share by Clayton Dubilier & Rice. MRW rejected the offer due to it undervaluing the supermarket chain and its future earnings and prospects.

MRW’s shares closed at GBX 240.20, sharply up by 34.60 per cent on 21 June.

  1. Avacta Group PLC (LON: AVCT)

FTSE AIM 100 constituent Avacta Group, a biotechnology company shares dropped by over 14 per cent on Monday despite signing a non-exclusive distribution agreement with life science products provider Calibre Scientific for the UK and European Economic Area (EEA) regions.

Avacta will distribute its AffiDX SARS-CoV-2 antigen lateral flow test targeted for professional use via the newly signed distribution agreement.

AVCT’s shares closed at GBX 182.00, down by 14.87 per cent on 21 June.

  1. Capita PLC (LON: CPI)

FTSE 250 listed company Capita is an international business outsourcing and professional services company. Its shares spiked on Monday after it announced its stake sale of Axelos, the joint venture between CPI and the Cabinet Office, for £380.0 million to PeopleCert International Limited.

CPI is set to receive £183.6 million in total net cash proceeds from the sale of its 51 per cent interest in Axelos.

CPI’s shares closed at GBX 41.08, up by 9.14 per cent on 21 June.


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is not authorised or regulated by the Financial Conduct Authority to provide regulated advice. The purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. The Content is guidance about the different types of investments that are available and sets out general principles to continue before making investment decisions. Kalkine Media is neither authorised nor qualified to provide regulated investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from an appropriately authorised and/or qualified financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

   

Kalkine

Rated 4.3/5 based on 904 Reviews at Google My Business